drugset / Trial / NCT07553442
A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy, pharmacodynamics (PD), and safety of ALN-AGT01 RVR in participants with mild to moderate hypertension pretreated with zilebesiran.
Timeline
- Start
- 2026-04-27
- Primary completion
- 2028-04-01
- Completion
- 2028-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ALN-AGT01 RVR | Unknown | — | Subcutaneous |
| Background | Zilebesiran | Unknown | — | Subcutaneous |